Davenport & CO LLC Protalix Bio Therapeutics, Inc. Transaction History

Davenport & CO LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	BUY	$1.02 - $1.56 $10,200 - $15,600	10,000 Added 83.33%	22,000 $24,000
Q4 2021 Feb 10, 2022	SELL	$0.81 - $1.33 $19,440 - $31,920	-24,000 Reduced 66.67%	12,000 $10,000
Q3 2021 Oct 14, 2021	BUY	$1.31 - $1.87 $31,440 - $44,880	24,000 Added 200.0%	36,000 $48,000
Q1 2021 Apr 28, 2021	BUY	$3.58 - $6.45 $42,960 - $77,400	12,000 New	12,000 $54,000

9.25M

40.6K

10.1K

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $57.7M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Davenport & CO LLC with notifications on news.